Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

被引：28
|
作者：
Chalhoub, Hussein [1 ]
Tunney, Michael [2 ]
Elborn, J. Stuart [2 ]
Vergison, Anne [3 ]
Denis, Olivier [4 ]
Plesiat, Patrick [5 ]
Kahl, Barbara C. [6 ]
Van Bambeke, Francoise [1 ]
Tulkens, Paul M. [1 ]
机构：
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmacol Cellulaire & Mol, B-1200 Brussels, Belgium
[2] Queens Univ Belfast, CF & Airways Microbiol Res Grp, Belfast, Antrim, North Ireland
[3] Hop Univ Enfants Reine Fabiola, Unite Malad Infect, Brussels, Belgium
[4] Free Univ Brussels, Hop Erasme, Lab Microbiol, B-1070 Brussels, Belgium
[5] Hop Jean Minjoz, Lab Bacteriol, F-25030 Besancon, France
[6] Univ Hosp Munster, Med Microbiol, Munster, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2015年 / 70卷 / 05期
关键词：
carbapenemases; extended-spectrum beta-lactamases; ESBLs; beta-lactamase inhibition; P; aeruginosa; IN-VITRO ACTIVITY; EXACERBATIONS;
D O I：
10.1093/jac/dku551
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1596 / 1598
页数：4
相关论文
共 50 条
  • [31] Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients
    Farfour, Eric
    Trochu, Erwan
    Devin, Clotilde
    Martin, Emilie Cardot
    Limousin, Lucie
    Roux, Antoine
    Picard, Clement
    Jolly, Emilie
    Vasse, Marc
    Lesprit, Philippe
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (05)
  • [32] In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients
    VanDevanter, Donald R.
    Van Dalfsen, Jill M.
    Burns, Jane L.
    Mayer-Hamblett, Nicole
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2015, 4 (02) : 151 - 154
  • [33] Comparison of agardilution and broth microdilution for the susceptibility testing of Pseudomonas aeruginosa isolates from Cystic Fibrosis patients
    Hogardt, M
    Schmoldt, S
    Götzfried, M
    Heesemann, J
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 : 232 - 233
  • [34] In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014)
    Nichols, Wright W.
    de Jonge, Boudewijn L. M.
    Kazmierczak, Krystyna M.
    Karlowsky, James A.
    Sahm, Daniel F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) : 4743 - 4749
  • [35] Performance evaluation of the βLACTA™ Test for rapid detection of ceftazidime resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Ract, Pauline
    Dahoumane, Redouane
    Gallah, Salah
    Morand, Philippe
    Podglajen, Isabelle
    Compain, Fabrics
    JOURNAL OF MICROBIOLOGICAL METHODS, 2019, 158 : 21 - 24
  • [36] Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients
    Marner, Michael
    Kolberg, Laura
    Horst, Julia
    Boehringer, Nils
    Huebner, Johannes
    Kresna, I. Dewa M.
    Liu, Yang
    Mettal, Ute
    Wang, Lei
    Meyer-Buehn, Melanie
    Mihajlovic, Sanja
    Kappler, Matthias
    Schaeberle, Till F.
    von Both, Ulrich
    MICROBIOLOGY SPECTRUM, 2023, 11 (01):
  • [37] The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages
    Essoh, Christiane
    Blouin, Yann
    Loukou, Guillaume
    Cablanmian, Arsher
    Lathro, Serge
    Kutter, Elizabeth
    Hoang Vu Thien
    Vergnaud, Gilles
    Pourcel, Christine
    PLOS ONE, 2013, 8 (04):
  • [38] Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye
    Buyukyanbolu, Ecem
    Genc, Leyla
    Cyr, Elizabeth A.
    Karakus, Mehmet
    Comert, Fusun
    Otlu, Baris
    Aktas, Elif
    Nicolau, David P.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (09) : 1787 - 1794
  • [39] Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary
    O'Neall, Dustin
    Juhasz, Emese
    Toth, Akos
    Urban, Edit
    Szabo, Judit
    Melegh, Szilvia
    Katona, Katalin
    Kristof, Katalin
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2020, 67 (01) : 61 - 65
  • [40] ANTIMICROBIAL ACTIVITY OF CEFTAZIDIME-AVIBACTAM AND COMPARATOR AGENTS AGAINST PSEUDOMONAS AERUGINOSA AND ENTEROBACTERALES CAUSING PNEUMONIA IN CYSTIC FIBROSIS PATIENTS
    Duncan, L. R.
    Streit, J. M.
    Castanheira, M.
    Sader, H. S.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S162 - S162
12345